OPIOID SERIES:

Trump's FDA nominee clears key Senate committee

Trump's FDA nominee clears key Senate committee
© Greg Nash

President Trump's nominee to lead the Food and Drug Administration (FDA) cleared a key Senate hurdle Thursday, putting him on track for a full Senate confirmation vote.

The Senate Health, Education, Labor and Pensions (HELP) Committee advanced Scott Gottlieb's nomination for FDA commissioner to the Senate floor on a 14-9 vote.

Committee chairman Lamar AlexanderAndrew (Lamar) Lamar AlexanderMaternal deaths keep rising in US, raising scrutiny Supreme Court weighs future of online sales taxes Senators press administration on mental health parity MORE (R-Tenn.) lauded Gottlieb for his experience and dismissed concerns from some Democrats over any potential conflicts of interest from Gottlieb's ties to health companies.

ADVERTISEMENT
Two Democrats joined the Republicans in voting for his nomination — Sens. Sheldon WhitehouseSheldon WhitehouseEPA inspector general to probe Pruitt's use of taxpayer-funded security detail on trips to Disneyland, Rose Bowl game Watchdog requests probe into relationship between top EPA aide and man investigating him Overnight Energy: Former Pruitt aide alleges more wasteful spending, retaliation | Senate confirms EPA No. 2 | Zinke backs off big park fee increases MORE (R.I.) and Michael BennetMichael Farrand BennetOvernight Health Care: GOP pushes stiff work requirements for food stamps | Johnny Isakson opens up about family's tragic loss to opioids | Republicans refuse to back vulnerable Dem's opioids bill | Dems offer new public option plan Lawmakers discuss Latino education gap The Hill's Morning Report: Hannity drawn into Cohen legal fight MORE (Colo.).

Gottlieb is a former FDA director of medical policy development and deputy commissioner, and the bipartisan HELP Committee vote is a sign he could be easily confirmed by the Senate. No date has been set for the full floor vote.